Disc Medicine, Inc. (NASDAQ:IRON – Get Free Report) Director William Richard White sold 2,560 shares of the firm’s stock in a transaction that occurred on Thursday, April 11th. The stock was sold at an average price of $31.80, for a total value of $81,408.00. The transaction was disclosed in a document filed with the SEC, […]
Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 19.3% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 26,819 shares of the company’s stock after purchasing an additional 4,332 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Akero […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) has been given a consensus rating of “Buy” by the eight brokerages that are presently covering the company, Marketbeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that have updated their coverage on the stock […]
Akero Therapeutics (NASDAQ:AKRO – Get Free Report) announced its quarterly earnings results on Monday. The company reported ($0.71) earnings per share for the quarter, missing the consensus estimate of ($0.70) by ($0.01), MarketWatch Earnings reports. Akero Therapeutics Stock Performance AKRO stock opened at $14.91 on Wednesday. The firm has a market cap of $829.00 million, […]
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) CFO William Richard White sold 632 shares of the business’s stock in a transaction on Wednesday, September 13th. The shares were sold at an average price of $50.34, for a total value of $31,814.88. Following the completion of the sale, the chief financial officer now directly owns […]